Skip to main content Accessibility help
×
Hostname: page-component-5c6d5d7d68-txr5j Total loading time: 0 Render date: 2024-08-30T05:27:55.920Z Has data issue: false hasContentIssue false

84 - Metaxalone

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Skelaxin

Generic?

• Yes

Class

• Muscle relaxant

Commonly Prescribed for

(FDA approved in bold)

Musculoskeletal conditions (adjunct to rest and physical therapy for relief of acute pain)

• Spasticity

How the Drug Works

• Unclear but might be related to general CNS depression effect

How Long Until It Works

• Pain: hours

If It Works

• Slowly titrate to most effective tolerated dose

If It Doesn't Work

• Increase to highest tolerated dose and consider alternative treatments

Best Augmenting Combos for Partial Response or Treatment-Resistance

• Use other centrally acting muscle relaxants with caution due to potential CNS depressant effect

• Can combine with NSAIDs for acute pain

Tests

• None

ADVERSE EFFECTS (AEs)

How the Drug Causes AEs

• CNS depression

Notable AEs

• Nausea, drowsiness, dizziness, headache, irritability, rash

Life-Threatening or Dangerous AEs

• Hemolytic anemia and leukopenia have been reported

Weight Gain

• Unusual

Sedation

• Common

What to Do About AEs

• Lower the dose or discontinue drug

Best Augmenting Agents to Reduce AEs

• Most AEs cannot be reduced by an augmenting agent

DOSING AND USE

Usual Dosage Range

• 800–3200mg/day

Dosage Forms

• Tablets: 800mg

How to Dose

• In children over 12 and adults, give 400–800mg 3–4 times daily

Dosing Tips

• Taking with food increases CNS depression

Overdose

• Overdose with alcohol can lead to death. Reports of serotonin syndrome. Treat with gastric lavage and supportive therapy

Long-Term Use

• Not well studied

Habit Forming

• No

How to Stop

• Taper not required

Pharmacokinetics

• Peak effect at 3 hours and half-life 9 hours. Hepatic metabolism to metabolites excreted in urine

Drug Interactions

• May enhance effect of other CNS depressants, such as alcohol, barbiturates, or benzodiazepines

Other Warnings/ Precautions

• May impair mental or physical abilities when driving or performing hazardous tasks

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 312 - 313
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Metaxalone
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.085
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Metaxalone
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.085
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Metaxalone
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.085
Available formats
×